RECENT PUBLICATIONS
🔹 New Research on Deep Learning in Diagnostic Neuropathology.
Dr. Stephen Yip and Dr. Ali Bashashati, along with their colleagues, have published an insightful paper on the practical application of deep learning in diagnostic neuropathology. This research explores how AI can transform histological analysis in the era of precision medicine. 🔗 Read the full paper.
🔹 Testing Equivalence in Disease Conditions.
Dr. Philipp Lange and his team have published a significant paper in the Journal of Proteome Research. The study, which emphasizes the importance of understanding what does not change across various conditions, establishes a statistical framework for testing equivalence in disease, biological, and technical conditions. 🔗 Read the full paper.
🔹 Advancing Cancer Treatment with DNA-PK Inhibitors.
Dr. Andrew I. Minchinton and his colleagues have published an impactful study demonstrating that the DNA-PK inhibitor AZD7648 is a more potent radiosensitizer than the PARP inhibitor Olaparib in BRCA1/2 deficient tumors. This finding could significantly advance treatment strategies for certain cancer patients. 🔗 Read the full paper.
🔹 Alzheimer's Disease and Plasma Biomarkers.
Jennifer Cooper, PhD candidate at UBC, along with Dr. Cheryl Wellington and colleagues, have published new research from her thesis. The study investigates the impact of the APOE4 genotype on Alzheimer's disease plasma biomarkers in a cognitively resilient senior population. The findings reveal that being an APOE4 carrier modifies p-tau-181 concentrations, highlighting its significance in interpreting biomarker levels regardless of clinical disease status. 🔗 Read the full paper.